July 02, 2025 03:00 ET | Source: Belite Bio, Inc - 500 subjects enrolled across the United States, the United…
GlucoModicum Reports Positive Clinical Results with its Needle-Free CGM and Advances Toward Market Launch Comprehensive clinical performance study encompassed 646…
OSE Immunotherapeutics provides an update on ongoing proceedings NANTES, France, July 2, 2025, 8 AM – OSE Immunotherapeutics SA (ISIN:…
Seattle, Washington, July 01, 2025 (GLOBE NEWSWIRE) -- Against the backdrop of the global transformation of clean energy and digital…
London, UK, July 01, 2025 (GLOBE NEWSWIRE) -- As Bitcoin (BTC) breaks through its all-time high in the first half…
New York, NY, July 01, 2025 (GLOBE NEWSWIRE) -- A Trusted Gateway to Risk-Free Crypto Earnings As financial uncertainty increases,…
Signed binding term sheet granting Intact Therapeutics an exclusive option to license PCS12852Continue enrolling patients in Phase 2 study of…
July 01, 2025 09:00 ET | Source: Inmagene Biopharmaceuticals The ADAPTIVE Phase 2b trial evaluates multiple dose regimens of IMG-007…
ESTERO, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- Visory Health, a leading patient-first health tech prescription platform that is transforming…
CALGARY, Alberta, June 30, 2025 (GLOBE NEWSWIRE) -- Acceleware® Ltd. (“Acceleware” or the “Company”) (TSX-V: AXE), a leading innovator of…